These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12856174)

  • 21. [Hypereosinophilic syndrome with DIC treated successfully with a combination of high-dose methylprednisolone and cyclosporin A].
    Fukuta A; Hara T; Tsurumi H; Moriwaki H
    Rinsho Ketsueki; 2001 Nov; 42(11):1145-7. PubMed ID: 11808087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of myelodysplastic syndrome with cyclosporin A.
    Chen S; Jiang B; Da W; Gong M; Guan M
    Int J Hematol; 2007 Jan; 85(1):11-7. PubMed ID: 17261496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of myelodysplasia with oral cyclosporin.
    Atoyebi W; Bywater L; Rawlings L; Brunskill S; Littlewood TJ
    Clin Lab Haematol; 2002 Aug; 24(4):211-4. PubMed ID: 12181023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
    Biesma DH; van den Tweel JG; Verdonck LF
    Cancer; 1997 Apr; 79(8):1548-51. PubMed ID: 9118037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
    Miyamae T; Nakasima S; Imagawa T; Ito S; Katakura S; Tomono N; Mori M; Ibe M; Mitsuda T; Aihara Y; Yokota S
    Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of TCM syndrome-typing based therapy combined with cyclosporin in treating myelodysplastic syndrome].
    Liu L; Shu X; Hu NP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Oct; 26(10):933-5. PubMed ID: 17121049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99).
    Hasegawa D; Manabe A; Yagasaki H; Ohtsuka Y; Inoue M; Kikuchi A; Ohara A; Tsuchida M; Kojima S; Nakahata T;
    Pediatr Blood Cancer; 2009 Dec; 53(6):1011-5. PubMed ID: 19499580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.
    Molldrem JJ; Leifer E; Bahceci E; Saunthararajah Y; Rivera M; Dunbar C; Liu J; Nakamura R; Young NS; Barrett AJ
    Ann Intern Med; 2002 Aug; 137(3):156-63. PubMed ID: 12160363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible acceleration of disease progression following cyclosporin A treatment in a patient with myelodysplastic syndrome.
    Itoh M; Yago K; Shimada H; Tohyama K
    Int J Hematol; 2002 Apr; 75(3):302-4. PubMed ID: 11999360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
    Xiao L; Qi Z; Qiusheng C; Li X; Luxi S; Lingyun W
    Am J Hematol; 2012 Jan; 87(1):26-31. PubMed ID: 22038646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of cyclosporine A treatment of patients with low-risk myelodysplastic syndrome: presence of CD55(-)CD59(-) blood cells predicts platelet response.
    Ishikawa T; Tohyama K; Nakao S; Yoshida Y; Teramura M; Motoji T; Takatoku M; Kurokawa M; Mitani K; Uchiyama T; Omine M
    Int J Hematol; 2007 Aug; 86(2):150-7. PubMed ID: 17875530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
    Dinçol G; Aktan M; Diz-Küçükkaya R; Yavuz S; Nalçaci M; Oztürk S; Palanduz S; Doğan O; Ağan M
    Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic effect of cyclosporin A combined with methylprednisolone pulse therapy on hemophagocytic syndrome with the central nervous system involvement].
    Yamamoto K; Otake M; Takayanagi M
    No To Hattatsu; 2002 Jan; 34(1):66-71. PubMed ID: 11808211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies.
    Catalano L; Selleri C; Califano C; Luciano L; Volpicelli M; Rocco S; Varriale G; Ricci P; Rotoli B
    Haematologica; 2000 Feb; 85(2):133-8. PubMed ID: 10681719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.
    El-Beshlawy A; Ibrahim IY; Rizk S; Eid K
    Pediatrics; 2002 Oct; 110(4):e44. PubMed ID: 12359817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real life experience with alemtuzumab treatment of patients with lower-risk MDS and a hypocellular bone marrow.
    Neukirchen J; Platzbecker U; Sockel K; Tsamaloukas A; Haas R; Germing U
    Ann Hematol; 2014 Jan; 93(1):65-9. PubMed ID: 23934199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes.
    Li X; Shi J; Wang M; Nie N; Shao Y; Ge M; Huang J; Huang Z; Zhang J; Zheng Y
    Acta Haematol; 2015; 134(3):138-45. PubMed ID: 25925993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
    Matsumoto H; Nakao T; Okada T; Nagaoka Y; Shino T; Yoshino M; Hidaka H
    Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.